Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease

Sommer, Annika, Marxreiter, Franz, Krach, Florian, Fadler, Tanja, Grosch, Janina, Maroni, Michele, Graef, Daniela, Eberhardt, Esther +8 more·2018·Cell Stem Cell

Cited by (331)

Items 201–300 of 331

  1. Neurotoxic properties of the Zika virus envelope protein
    Joseph P. Steiner, Muznabanu Bachani, Nasir Malik, Wenxue Li, Richa Tyagi, Kevon Sampson, Rachel P. M. Abrams, Youssef A. Kousa, Jamie Solis, Tory P. Johnson et al. · 2023 · Experimental Neurology
  2. Interleukin-17A Promotes Proliferation and Osteogenic Differentiation of Human Ligamentum Flavum Cells Through Regulation of β-Catenin Signaling
    Jialiang Lin, Shuai Jiang, Qian Xiang, Yongzhao Zhao, Longjie Wang, Dongwei Fan, Woquan Zhong, Chuiguo Sun, Zhongqiang Chen, Weishi Li · 2023 · Spine
  3. Effects of anesthetic method on inflammatory response in patients with Parkinson’s disease: a randomized controlled study
    Wonjung Hwang, Min A. Joo, Jin Deok Joo · 2020 · BMC Anesthesiology
  4. Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines
    Veronika Sigutova, Wei Xiang, Martin Regensburger, Beate Winner, Iryna Prots · 2024 · Brain Behavior and Immunity
  5. Bidirectional interaction between IL and 17A/IL-17RA pathway dysregulation and α-synuclein in the pathogenesis of Parkinson’s disease
    Yu‐Chen Yan, Lu Su, W Zhao, Yun Fan, James B. Koprich, Bao‐Guo Xiao, Bin Song, Jian Wang, Wenbo Yu · 2024 · Brain Behavior and Immunity
  6. Myelin organoids for the study of Alzheimer's disease
    Jonas Cerneckis, Yanhong Shi · 2023 · Frontiers in Neuroscience
  7. Conditional knockout of Tsc1 in RORγt-expressing cells induces brain damage and early death in mice
    Yafei Deng, Yang Yao, Yao Yang, Yana Li, Hongyan Peng, Shuting Wu, Shuju Zhang, Baige Yao, Shuhui Li, Yuan Gao et al. · 2021 · Journal of Neuroinflammation
  8. Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease
    Martin J. Page, Etheresia Pretorius · 2021 · Seminars in Thrombosis and Hemostasis
  9. Role of T cell-induced autoimmune response in the pathogenesis of glaucoma
    Shuxin Liang · 2024 · International Ophthalmology
  10. Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases
    Jiaxuan Li, Naihui Mao, Ying Wang, Shuli Deng, Keda Chen · 2024 · Molecular Therapy
  11. The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson’s disease
    Yuan-Kai Cheng, Hao-Sen Chiang · 2025 · Neurological Sciences
  12. Nardostachys jatamansi Extract and Nardosinone Exert Neuroprotective Effects by Suppressing Glucose Metabolic Reprogramming and Modulating T Cell Infiltration
    Congyan Duan, Weifang Lin, Mingjie Zhang, Bian‐Xia Xue, Wangjie Sun, Jin Yang, Xiaoxu Zhang, Hong Wei Guo, Qing Yuan, Mingyu Yu et al. · 2025 · Cells
  13. The role of interleukin-17 in neurological disorders
    Seung Eun Park, Ana Flávia Fernandes Ferreira, Hyeokbin Kwon, Jeongwoo Yu, Leila Diniz, Henning Ulrich, Luiz R.G. Britto, Eunha Kim · 2025 · Animal Cells and Systems
  14. The autoimmune response induced by α-synuclein peptides drives neuronal cell death and glial cell activation
    Yong‐Ho Choe, Min Gi Jo, Bo Gyu Kim, Sangwon Lee, Bina Lee, Seon‐Hee Kim, Hyemin Seong, Woong-Sun Yoo, Minkyeong Kim, Dong‐Kun Lee et al. · 2024 · Journal of Autoimmunity
  15. A compendious summary of Parkinson’s disease patient-derived iPSCs in the first decade
    Chao Ren, Fen Wang, Li-Na Guan, Xiao-Yu Cheng, Cai-Yi Zhang, Deqin Geng, Chun‐Feng Liu · 2019 · Annals of Translational Medicine
  16. Immune-microbiome interplay and its implications in neurodegenerative disorders
    Ankit Uniyal, Vineeta Tiwari, Mousmi Rani, Vinod Tiwari · 2021 · Metabolic Brain Disease
  17. Disease mechanisms as subtypes: Inflammation in Parkinson disease and related disorders
    David G. Standaert, Ashley S. Harms, Gabrielle M. Childers, Jhodi M. Webster · 2023 · Handbook of clinical neurology
  18. CCL5 promotes LFA-1 expression in Th17 cells and induces LCK and ZAP70 activation in a mouse model of Parkinson’s disease
    Jingwei Zhao, Zhijuan Mao, Qu Yi, Danlei Wang, Jiangting Li, Ke An, Zhe Min, Zheng Xue · 2023 · Frontiers in Aging Neuroscience
  19. Correlation of inflammatory markers with depression and sleep disorders accompanying the prodromal stage of Parkinson’s disease
    Chengguang Zhang, Yu Zhang, Ke Yi Xu, Shun Wang, Yan Bai · 2025 · World Journal of Psychiatry
  20. Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice
    Julia Rosauro Clarke, Thiago de Sá Bacelar, Gabriel Gripp Fernandes, Raquel Costa da Silva, Leticia S. Antonio, Mariana Queiroz, Renata Vieira Souza, Leticia F. Valadão, Gabriel S. Ribeiro, Emanuelle Vasconcellos de Lima et al. · 2024 · Molecular Psychiatry
  21. Dissecting the immune response of CD4+ T cells in Alzheimer’s disease
    Miloš S. Kostić, Nikola Živković, Ana Cvetanović, Jelena Bašić, Ivana R. Stojanović · 2024 · Reviews in the Neurosciences
  22. Emerging Targets for the Diagnosis of Parkinson’S Disease: Examination of Systemic Biomarkers
    Lara Cheslow, Adam Eugene Snook, Scott Arthur Waldman · 2021 · Biomarkers in Medicine
  23. Decoding Parkinson's disease – iPSC-derived models in the OMICs era
    Florian Krach, Marios Bogiongko, Beate Winner · 2020 · Molecular and Cellular Neuroscience
  24. Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
    Cristoforo Comi, Marco Cosentino, Rodrigo Pacheco · 2019 · Frontiers in Neurology
  25. FDA-Approved Secukinumab Alleviates Glial Activation and Immune Cell Infiltration in MPTP-Induced Mouse Model of Parkinson’s Disease
    Qi Li, Xiaoxuan Han, Mengmeng Dong, Lipeng Bai, Wei Zhang, Wei Liu, Fei Wang, Xiaodong Zhu · 2025 · Inflammation
  26. CD4 + T cell‐associated cytokines induce a chronic pro‐inflammatory phenotype in induced pluripotent stem cell‐derived midbrain astrocytes
    Adina N. MacMahon Copas, Sarah F. McComish, Andreea Petrasca, Rachel McCormack, Daniel Ivers, Anna Stricker, Jean M. Fletcher, Maeve A. Caldwell · 2024 · Glia
  27. Hidden face of Parkinson’s disease: Is it a new autoimmune disease?
    Min Gi Jo, Seon‐Hee Kim, Seung Pil Yun · 2024 · Neural Regeneration Research
  28. Neuroinflammation and Reconsolidation of Memory
    G. A. Grigoryan · 2022 · Neurochemical Journal
  29. Glycolipids in Parkinson's disease: beyond neuronal function
    Fokion Spanos, Michela Deleidi · 2023 · FEBS Open Bio
  30. Induced pluripotent stem cell models for advancing neurodevelopmental disorder research and regenerative medicine: a narrative review
    Moawiah M. Naffaa · 2025 · Regenerative medicine reports .
  31. Differential gene expression and immune profiling in Parkinson’s disease: unveiling potential candidate biomarkers
    Xiuping Yao, Peng Wang, Zhenqiang Huang, Lingyun Li · 2025 · BMC Neurology
  32. Bibliometric analysis of global research trends on regulatory T cells in neurological diseases
    Qian Gao, Xinmin Li, Yan Li, Junzi Long, Mengyang Pan, Jing Wang, Fangjie Yang, Yasu Zhang · 2023 · Frontiers in Neurology
  33. Genetic causal relationship between multiple immune cell phenotypes and Parkinson’s disease: a two-sample bidirectional Mendelian randomization study
    Hong Chen, Wang Xie, Ze Chang, Juan Zhang, Daojun Xie · 2024 · Journal of Neurophysiology
  34. The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis
    Lukas Leupold, Veronika Sigutova, Elizaveta M. Gerasimova, Martin Regensburger, Sebastian Zundler, Friederike Zunke, Wei Xiang, Beate Winner, Iryna Prots · 2022 · Frontiers in Neurology
  35. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV- α -synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease
    Filip Fredlund, Itzia Jiménez-Ferrer, Kathleen Grabert, Lautaro F. Belfiori-Carrasco, Kelvin C. Luk, Maria Swanberg · 2024 · Journal of Parkinson s Disease
  36. The combination of forskolin and VPA increases gene expression efficiency to the hypoxia/neuron-specific system
    Zhimin Pan, Jinsoo Oh, Lu Huang, Zhaoxun Zeng, Pingguo Duan, Zhiyun Li, Yeomin Yun, Janghwan Kim, Yoon Soo Ha, Kai Cao · 2020 · Annals of Translational Medicine
  37. Impact of Aging and Cellular Senescence in the Pathophysiology of Preeclampsia
    Sonja R. Suvakov, Andrea G. Kattah, Tamara Gojković, Elizabeth Ann L. Enninga, Jacob E. Pruett, Muthuvel Jayachandran, Círia Sousa, Janelle Santos, Coline Abou Hassan, Maria Lourdes Gonzalez Suarez et al. · 2023 · Comprehensive physiology
  38. Delphinidin modulates neuroinflammation and behavioral deficits in a Parkinson’s disease mouse model
    Alexander Grotemeyer, S. Alexander, L. Frieß, Joachim Roewer, Ezgi Eyluel Bankoglu, Mohammad Badr, J. Wu, Helga Stopper, J. Volkmann, Norbert Roewer et al. · 2026 · npj Parkinson s Disease
  39. The HALP score differs among sporadic and familial Parkinson's disease
    Wen Zhou, Qingqing Xia, Duan Liu, Jun Ying Li, Liang Gong · 2025 · Parkinsonism & Related Disorders
  40. Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease
    Zhiling Zhang, Panghai Ye, Wei-Xin Kong, Jin Li, Si Zhu, Yu-Wan Lin, Pingyi Xu, Wenyuan Guo · 2025 · Molecular Neurobiology
  41. Curative Anti‐Inflammatory Properties of Chinese Optimized Yinxieling Formula in Models of Parkinson’s Disease
    Renrong Wei, Ouyang Jing, Weixian Lin, Tongxiang Lin · 2018 · Evidence-based Complementary and Alternative Medicine
  42. Is Cellular Senescence of Dopaminergic Neurons the Cause of Local Inflammation in the Midbrain Observed in Parkinson’s Disease?
    Markus Rießland · 2020 · Journal of Cellular Immunology
  43. Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications
    Chloe Sligar, Ronald Sluyter, Lezanne Ooi · 2026 · Journal of Neuroinflammation
  44. Potential Protection Against Parkinson’s Disease by Ergothioneine—Nature’s Multifactorial Neuroprotectant
    Teddy J. W. Tng, Irwin Kee-Mun Cheah, Barry B. Halliwell, Kah‐Leong Lim · 2026 · Antioxidants
  45. Emerging targets signaling for inflammation in Parkinson’s disease drug discovery
    Rhema Chandan Khairnar, Niraj Parihar, Kedar Sudhir Prabhavalkar, Lokesh Kumar Bhatt · 2022 · Metabolic Brain Disease
  46. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis
    Steven D. Willows, Syed Benazir Alam, Jagdeep K. Sandhu, Marianna Kulka · 2020 · Biochemistry and Cell Biology
  47. The application of iPSCs in Parkinson’s disease
    Josefine Jul Jarbæk Nielsen, Thea Pinholt Lillethorup, Andreas Nørgaard Glud, Jens Christian Hedemann Sørensen, Dariusz Orłowski · 2020 · Acta Neurobiologiae Experimentalis
  48. Role of CD4+ T Cells in Parkinson's Disease
    Mohan Krishna Ghanta, Poojith Nuthalapati, Neha Merchant, Santenna Chenchula, Faiz Hussain, Afzal Khan Ak, Lakkakula VKS Bhaskar · 2022 · Critical Reviews in Immunology
  49. Deciphering Brain Organoids Heterogeneity by Identifying Key Quality Determinants
    Daniel V. Kachkin, Naime Zagha, Tom Boerstler, Federica Furlanetto, Negar Nayebzade, Luke Zappia, Michelle Boisvert, Michaela Farrell, Sonja Ploetz, Martin Regensburger et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Neuroimmune crosstalk in Parkinson’s disease: the pivotal role of microglia and infiltrating T cells
    Xinze Li, Wangjie Sun, Wenmo Chen, Naixuan Wang, Shaoxia Wang · 2025 · Molecular Biology Reports
  51. Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson’s disease
    Alex Tchung, Amandine Even, Louis‐Éric Trudeau · 2026 · Trends in Neurosciences
  52. DYRK1A and Parkinson’s disease, facts and hypotheses
    Laurent Meijer, Mattias F. Lindberg, Gaëlle Hogrel, Bernard Khor · 2026 · Neurobiology of Disease
  53. Antigen-specific adaptive immunity in Parkinson’s disease: peripheral priming, brain-border reactivation and parenchymal injury
    Kehao Wang, Ke Han, Yanqing Wang · 2026 · Journal of Neuroinflammation
  54. Adaptive immunity in the pathogenesis of neurodegeneration
    Yongyi Li, Jason D. Ulrich, David M. Holtzman · 2026 · Nature Immunology
  55. Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies
    Qin-qin Wang, Qing-qing Sun, Yong-shun Guo, Shu Yin, Jiawei Zhou · 2026 · Translational Neurodegeneration
  56. Immunology and microbiome: Implications for motor systems
    Yasamin Mahjoub, Davide Martino · 2023 · Handbook of clinical neurology
  57. Neuroinflammation and Immune Dysfunction in the Mechanisms of Development of Parkinson’s Disease
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Neuroscience and Behavioral Physiology
  58. NPT100-18A rescues mitochondrial oxidative stress and neuronal degeneration in human iPSC-based Parkinson’s model
    Julian E. Alecu, Veronika Sigutova, Razvan-Marius Brazdis, Sandra Lörentz, Marios Bogiongko, Anara Nursaitova, Martin Regensburger, Laurent Roybon, Kerstin M. Galler, Wolfgang Wrasidlo et al. · 2025 · BMC Neuroscience
  59. Renin–Angiotensin System Autoantibody Network in Parkinson’s Disease Patients
    Carmen M. Labandeira, Laura Camacho-Meño, Paula Aracil‐Pastor, Juan Antonio Suárez-Quintanilla, José Luis Labandeira-García, Ana Isabel Rodriguez-Perez · 2025 · Antioxidants
  60. Multimodal relationships and multifactorial associations between oral microecological and neurodegenerative diseases
    Yi Zhou, Jiaxuan Li, Di Wang, Ling Peng, Keda Chen · 2025 · Neuropharmacology
  61. Th17 lymphocyte spearheads the immune attack in Parkinson's disease: New evidence for neuronal death
    Aparna Wagle Shukla, Susan Helen Fox · 2018 · Movement Disorders
  62. Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells
    George E. Allen, Aaron S. Dhanda, Lisa M. Julian · 2022 · Methods in molecular biology
  63. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease
    Elena Contaldi, Luca Magistrelli, Cristoforo Comi · 2023 · Handbook of clinical neurology
  64. Characterization of the Th17 profile immune response in cases of human rabies transmitted by dogs and its interference in the disease pathogenesis.
    Liette Benedita C. dos Santos, Fernanda Guedes, Samira Maria Achkar, Maria Irma Seixas Duarte, Iana Suly Santos Katz, Sávio Ricardo De Oliveira Silva, Elaine Raniero Fernandes · 2020 · Journal of Neuroimmunology
  65. Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases
    Katherine E. Olson, Rodney Lee Mosley, Howard Eliot Gendelman · 2020 · Springer eBooks
  66. Lead Phytomolecules for Treating Parkinson’s Disease
    Krishn Kumar Agrawal, Chandra Veer, Yogesh Murti, Sunil Pratap Singh · 2024 · Central Nervous System Agents in Medicinal Chemistry
  67. Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson’s Disease Pathogenesis and Drug Screening
    Jihong Liu, Wanlin Zhao, Zijuan Zhang, Xilei Ai, Bing Cao, Zhenqiang Zhang, Dongrui Ma · 2025 · Stem Cell Reviews and Reports
  68. Alpha synuclein-mediated cytoskeletal dysfunction impairs myelination in human oligodendrocytes
    Jeanette Wihan, Kristina Battis, Alana Hoffmann, Farina Windener, Marcus Himmler, Anish Varghese, Aron Koller, Isabell Karnatz, Dirk Wolfram Schubert, Friederike Zunke et al. · 2025 · Acta Neuropathologica
  69. Parkinson's disease: A chronic systemic inflammatory disorder
    Hina Khan, Matthew J. Benskey · 2025 · Handbook of behavioral neuroscience
  70. Reinventing brain immunity in neurodegeneration
    Huachen Huang, Yali Han, Zhaoli Han, Huaijin Yang, Ying Fu, Qiang Liu · 2025 · Immunity & Inflammation
  71. Akkermansia muciniphila: A double-edged sword in life-stage-specific nutritional modulation of Parkinson’s disease via the gut-brain axis
    Nan Chen, Dejiang Pang, Huifang Shang · 2025 · Microbiological Research
  72. The role of Th17 cells in the pathogenesis of Parkinson's disease: From immune dysregulation to neurodegeneration
    Jinyue Zhao, Huazheng Liang, Yong Bi · 2026 · Brain Research Bulletin
  73. Diet, mycobiome and virome: from mucosal immunity to gut–brain axis regulation
    Alessandro Medoro, Andrea Castagnetti, Mariano Intrieri, Giovanni Scapagnini, Sergio Davinelli · 2026 · Frontiers in Nutrition
  74. Immune-mediated excitotoxicity in brain disorders
    Josef Shin, Christina Francisca Vogelaar, Stefan Bittner, Frauke Zipp · 2026 · Nature reviews. Immunology
  75. NEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Журнал высшей нервной деятельности им И П Павлова
  76. Impact of Aging and Cellular Senescence in the Pathophysiology of Preeclampsia
    Sonja R. Suvakov, Andrea G. Kattah, Tamara Gojković, Elizabeth Ann L. Enninga, Jacob E. Pruett, Muthuvel Jayachandran, Círia Sousa, Janelle Santos, Coline Abou Hassan, Maria Lourdes Gonzalez Suarez et al. · 2023 · Comprehensive physiology
  77. Aspergillusidone G Exerts Anti-Neuroinflammatory Effects via Inhibiting MMP9 Through Integrated Bioinformatics and Experimental Analysis: Implications for Parkinson’s Disease Intervention
    Fangfang Ban, Longjian Zhou, Zhiyou Yang, Yayue Liu, Yi Zhang · 2025 · Marine Drugs
  78. Роль Т-клеточных субпопуляций в патогенезе и терапии болезни Паркинсона (обзор литературы)
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Сибирский вестник психиатрии и наркологии
  79. Parkinson- und Alzheimer-Erkrankung als Systemerkrankungen
    Thorsten Bartsch, Daniela Berg, Michael Thomas Heneka, Frank Leypoldt · 2023 · Der Nervenarzt
  80. At the Bench-Parkinson's Disease
    Jamie Talan · 2018 · Neurology Today
  81. Interferon-γ signaling synergizes with LRRK2 in human neurons and microglia
    Silvia De Cicco, Dina Ivanyuk, Wadood Haq, Vasiliki Panagiotakopoulou, Aleksandra Arsić, David C. Schöndorf, Cong Yu, Maria Jose Perez J., Ruggiero Pio Cassatella, Meike Jakobi et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  82. inmunidad en enfermedades autoinmunes
    Martin Eduardo Torres-Velasco, Signe María Gómez-Hollsten, Esteban Uriel Montes-Moratilla, Laura Virginia Adalid-Peralta · 2020 · Archivos de Neurociencias
  83. Combination of GSK3 and HDAC inhibitors increases gene expression efficiency to the hypoxia/neuron- specific system : an optimal experimental scheme in treating spinal cord injury
    Zhimin Pan · 2020
  84. Studying non–cell-autonomous neurodegeneration in Parkinson’s disease with induced pluripotent stem cells
    Tuuli-Maria Sonninen, L. M. Plotnikova, Nihay Laham-Karam, Gundars Goldsteins, Jari Koıstınaho, Šárka Lehtonen · 2021 · Elsevier eBooks
  85. Interleukin-17A promotes proliferation and osteogenic differentiation of human ligamentum flavum cells through regulation of β-catenin nuclear translocation
    Jialiang Lin, Shuai Jiang, Qian Xiang, Yongzhao Zhao, Longjie Wang, Dongwei Fan, Woquan Zhong, Chuiguo Sun, Zhongqiang Chen, Weishi Li · 2022 · Research Square
  86. MHC class II transactivator effects on local and systemic immune responses in an α-synuclein seeded rat model for Parkinson’s disease
    Filip Fredlund, Itzia Jiménez-Ferrer, Kathleen Grabert, Lautaro F. Belfiori-Carrasco, Kelvin C. Luk, Maria Swanberg · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  87. The MHC class II transactivator affects local and systemic immune responses in an α-synuclein seeded rat model for Parkinson’s disease
    Filip Bäckström, Itzia Jiménez-Ferrer, Kathleen Grabert, Lautaro F. Belfiori-Carrasco, Kelvin C. Luk, Maria Swanberg · 2023 · Research Square
  88. Parkinson's disease
    2023 · Advances in magnetic resonance technology and applications
  89. Peripheral Mononuclear Cell Cerna Analysis and Immunoinfiltration Analysis in Parkinson's Disease
    Lijun Guo, Qiong Li, Jingyi Jessica Li, Feng Hua Yang · 2024 · SSRN Electronic Journal
  90. Circulating inflammatory proteins and risk of Parkinson’s disease and other neurodegenerative disorders: a two-sample Mendelian randomization study
    Zhichun Chen, Guanglu Li, Liche Zhou, Lina Zhang, Yong You, Jun Liu · 2024 · medRxiv
  91. Sequential infiltration of Th17 cells into the substantia nigra in a primate model of Parkinson's disease
    Jincheol Seo, Thanh Thi Hai Nguyen, Jinyoung Won, Chang‐Yeop Jeon, Seung Ho Baek, Junghyung Park, Jung Bae Seong, Hyeon-Gu Yeo, Keon Woo Kim, Lee Wha Gwon et al. · 2024 · Research Square
  92. Epigenetic effects of AtreMorine in Parkinson’s disease
    Vinogran Naidoo, Olaia A. Martínez-Iglesias, Ramón Cacabelos · 2025 · Elsevier eBooks
  93. A Seven-Gene Signature for the Diagnosis of Parkinson’s Disease and Immune Infiltration Analysis
    Chengqun Wei, Rui Xue, Zhan Gao, Hongyan Zhu, Xiuzhi Xu · 2025 · Twin Research and Human Genetics
  94. The Neuroimmune Landscape of the Lysosomal Storage Disorder Sanfilippo Syndrome
    Rafael A. Badell‐Grau, Johannes C. M. Schlachetzki · 2025 · BioEssays
  95. Early Aging of the Brain in Rats: Insights from Two Markers, IL-17 and Aquaporin-4, and Region-Specific Glial and Vascular Alterations in the Hippocampus
    Chloé Mounichetty, Fabien Forest, Nathalie Perek, Frédéric Roche · 2025 · Neuroglia
  96. Additional file 2 of Conditional knockout of Tsc1 in RORγt-expressing cells induces brain damage and early death in mice
    Deng, Yafei, Yang, Qinglan, Yang, Yao, Yana Li, PENG Hongyan, Shuting Wu, Zhang, Shuju, Baige Yao, Li, Shuhui, Gao, Yuan et al. · 2021 · Figshare
  97. Additional file 1 of Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies
    Lee, Eun Ji, Yoori Choi, Lee, Hong J., Hwang, Do Won, Dong Soo Lee · 2022 · Figshare
  98. Additional file 7 of Conditional knockout of Tsc1 in RORγt-expressing cells induces brain damage and early death in mice
    Deng, Yafei, Yang, Qinglan, Yang, Yao, Yana Li, PENG Hongyan, Wu, Shuting, Zhang, Shuju, Baige Yao, Li, Shuhui, Gao, Yuan et al. · 2021 · Figshare
  99. Additional file 2 of Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice
    Feng, Yu-Kun, Wu, Qiong-Li, Peng, Yan-Wen, Liang, Feng-Yin, You, Hua-Jing, Feng, Yi-Wei, Li, Ge, Li, Xue-Jiao, Liu, Shu-Hua, Li, Yong-Chao et al. · 2020 · Figshare
  100. Additional file 2 of Neuroinflammation and protein pathology in Parkinson’s disease dementia
    Antonina Kouli, Camacho, Marta, Allinson, Kieren, Caroline H. Williams‐Gray · 2020 · Figshare